MESOBLAST LTD (MESO) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MESO currently has 1.29B outstanding shares. with limited dilution risk as only 128M additional shares (9.9%) are authorized for issuance. The company has diluted shareholders by 12.89% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Dec 30, 2025 |
F-3 filing: This prospectus relates to the offer and sale from time to time by the shareholders identified in this prospectus of up to 5,000,000 ordinary shares (represented by 500,000 ADSs) issuable upon the exercise of warrants of Mesoblast Limited. |
1.3B | 130M |
| Feb 05, 2025 |
F-3 filing: This prospectus relates to the offer and sale by the Shareholders of 34,675,000 ordinary shares as represented by ADSs sold in the Private Placement. |
1.3B | 120M |
| Dec 13, 2024 |
F-3 filing: An F-3 filing for the offering of 200,000 ADSs representing 2,000,000 ordinary shares by a shareholder. The company will not receive any proceeds from the sale of the ADSs. |
1.1B | 88M |
| Aug 29, 2024 |
20-F filing | 1141.8M shares outstanding |
1.1B | 86M |
| Apr 16, 2024 |
F-3 filing: F-3 filing for the offering of 5,800,000 ADSs representing 58,000,000 ordinary shares by selling shareholders. |
1.1B | 86M |
| Aug 31, 2023 |
20-F filing | 814.2M shares outstanding |
810M | 28M |
| May 18, 2023 |
F-3 filing: F-3 filing for the offering of 3,637,635 ADSs representing 18,188,175 ordinary shares by selling shareholders. |
810M | 28M |
| Mar 24, 2023 |
F-3 filing: This F-3 filing relates to the offer and sale from time to time by the Oaktree Shareholders of up to 2,275,000 ordinary shares of Mesoblast Limited, represented by 455,000 American Depositary Shares. |
740M | 10M |
| Dec 20, 2022 |
POS AM filing: This is a POS AM filing from Mesoblast Limited regarding the offer and sale from time to time by the Oaktree Shareholders of up to 8,848,345 ordinary shares, represented by 1,769,669 American Depositary Shares. |
750M | 7.7M |
| Dec 20, 2022 |
F-3 filing: The filing relates to a shelf offering of American Depositary Shares (ADSs) representing ordinary shares. The ADSs may be offered from time to time in one or more offerings, with terms and offering prices to be determined at the time of the offering. |
740M | 7.7M |
| Aug 31, 2022 |
20-F filing | 650.5M shares outstanding |
650M | 7.7M |
| Aug 31, 2022 |
F-3 filing: This F-3 filing relates to the offer and sale from time to time by the selling shareholders of up to 7,692,310 ordinary shares of Mesoblast Limited, represented by 1,538,462 American Depositary Shares. |
740M | 7.7M |
| Aug 31, 2021 |
20-F filing | 648.7M shares outstanding |
650M | 0 |
| Sep 03, 2020 |
20-F filing | 583.9M shares outstanding |
580M | 0 |